Prevention by gamma interferon of fatal infection with Listeria monocytogenes in mice treated with cyclosporin A.
The significance of interferons (IFNs) induced by Listeria monocytogenes in the antilisterial defense mechanism was studied in mice. Cyclosporin A (CsA) had no effect on IFN-alpha production that was induced in the bloodstream after intravenous infection of mice with L. monocytogenes, whereas IFN-gamma that was induced in the bloodstreams of control mice 6 h after stimulation with specific antigen in the late phase of infection was suppressed in CsA-treated mice, depending on the dose of the drug injected. The decrease in IFN-gamma production caused an increase in bacterial growth in the spleens and livers of CsA-treated mice. Furthermore, administration of a daily dose of CsA at 80 or 100 mg/kg of body weight resulted in fatal listeriosis, even though the dose was nonlethal for normal mice. The administration of recombinant murine IFN-gamma on day 0 of L. monocytogenes infection prevented CsA-treated mice from developing fatal listeriosis and restored their ability to produce IFN-gamma in the bloodstream, in response to specific antigen in the late phase of infection.
D000818:Animals; D003524:Cyclosporins / Q000494:pharmacology*; D005260:Female; D007165:Immunosuppression Therapy; D007370:Interferon Type I / Q000096:biosynthesis; D007371:Interferon-gamma / Q000096:biosynthesis / Q000627:therapeutic use*; D008089:Listeria monocytogenes / Q000254:growth & development / Q000276:immunology; D008088:Listeriosis / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D009894:Opportunistic Infections / Q000517:prevention & control*; D011994:Recombinant Proteins; D013997:Time Factors
D003524:Cyclosporins; D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma